{"nctId":"NCT01973452","briefTitle":"Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery","startDateStruct":{"date":"2013-10","type":"ACTUAL"},"conditions":["Pain"],"count":333,"armGroups":[{"label":"Dexmedetomidine","type":"EXPERIMENTAL","interventionNames":["Drug: Dexmedetomidine"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Dexmedetomidine","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adult patients ( â‰¥ 21 years old) scheduled for Thoracic Surgery\n\nExclusion Criteria:\n\n* 2nd or 3rd degree heart block as assessed by preoperative EKG\n* Use of dexmedetomidine within 28 days prior to day of surgery\n* Use of long acting opioids pre-operatively 28 days prior to day of surgery\n* Current or past diagnosis of a Major Psychiatric disorder precluding adequate outcome responses such as Schizophrenia, dementia, delirium etc. as recorded in the Pre-Operative Record.\n* Documentation of congestive heart failure and Ejection fraction \\< 30% if recorded in the Pre-Operative Record.\n* Planned use of an epidural for surgery or post-operative pain relief\n* Contraindication to use of NSAID, Acetaminophen or IV opioids.\n* Any known hypersensitivity to dexmedetomidine\n* Pregnant or breastfeeding\n* Abnormal liver function tests as related to the MSK guidelines for use of IV Acetaminophen\n\nYes or NO?; Is ALT greater than 2 x Upper Limit of Normal (\\> 75 U/L)?\n\n* Abnormal renal function tests as related to contraindications to use of IV Ketorolac\n\nYes or No?; Is Serum Creatinine \\< 1.5 mg/dl?","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Total Opioid Administered","description":"total opioid equivalents used postoperatively as measured by the total opioid administered in approximately the first 4 hours","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":null},{"groupId":"OG001","value":"6.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Improves Analgesia","description":"as measured by change in Pain Numerical Rating Scale (NRS) preoperatively to postoperatively at rest and with activity (such as coughing). In the Pain Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":null},{"groupId":"OG001","value":"4.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Episodes of Nausea or Antiemetic Doses and/or Sedation","description":"as measured by incidence of recorded nausea or the use of antiemetics and RASS sedation scores, respectively.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null},{"groupId":"OG001","value":"110","spread":null}]},{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":148},"commonTop":[]}}}